tiprankstipranks
Trending News
More News >
Foghorn Therapeutics (FHTX)
NASDAQ:FHTX
US Market

Foghorn Therapeutics (FHTX) Income Statement

Compare
404 Followers

Foghorn Therapeutics Income Statement

Last quarter (Q4 2024), Foghorn Therapeutics's total revenue was $2.86M, a decrease of -50.49% from the same quarter last year. In Q4, Foghorn Therapeutics's net income was $-19.50M. See Foghorn Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 22.60M$ 34.16M$ 19.23M$ 1.32M$ 430.00K
Gross Profit
$ 22.60M$ -75.53M$ 19.21M$ -6.20M$ -57.28M
Operating Expenses
$ 125.28M$ 142.06M$ 136.37M$ 102.05M$ 68.96M
Depreciation and Amortization
$ 3.12M$ 3.45M$ 7.90M$ 7.51M$ 5.53M
EBITDA
$ -97.17M$ -104.45M$ -113.82M$ -96.19M$ -66.49M
Operating Income
$ -102.68M$ -107.91M$ -117.14M$ -100.73M$ -68.53M
Other Income/Expenses
$ 16.06M$ 13.71M$ 8.26M$ -586.00K$ -269.00K
Pretax Income
$ -86.62M$ -94.20M$ -108.88M$ -101.32M$ -68.80M
Net Income
$ -86.62M$ -98.43M$ -108.87M$ -103.23M$ -69.78M
Per Share Metrics
Basic EPS
$ -1.58$ -2.34$ -2.62$ -2.78$ -1.90
Diluted EPS
$ -1.58$ -2.34$ -2.62$ -2.78$ -1.90
Weighted Average Shares Outstanding
54.90M 41.97M 41.59M 37.17M 36.79M
Weighted Average Shares Outstanding (Diluted)
54.90M 41.97M 41.59M 37.17M 36.79M
Currency in USD

Foghorn Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis